[Recent insights into mechanisms for analgesic effect by calcitonin].
Ito
Akitoshi
A
Research Center, Asahi Kasei Pharma Co. Ltd.
Furue
Hidemasa
H
Yoshimura
Megumu
M
D000200:Action Potentials; D000818:Animals; D001416:Back Pain / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D050071:Bone Density Conservation Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002116:Calcitonin / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D036421:Nerve Fibers, Unmyelinated / Q000502:physiology; D010024:Osteoporosis / Q000150:complications; D010052:Ovariectomy; D051381:Rats; D012701:Serotonin / Q000502:physiology; D015222:Sodium Channels / Q000502:physiology; D013121:Spinal Curvatures / Q000150:complications; D016103:Spinal Fractures / Q000150:complications
D050071:Bone Density Conservation Agents; D015222:Sodium Channels; D012701:Serotonin; D002116:Calcitonin